Percutaneous closure of perimembranous and muscular ventricular septal defects in the same session in a pediatric patient
Öz
Abstract
Ventricular septal defect closure is proposed because of some possible complications such as left heart failure, pulmonary vascular disease, Eisenmenger's syndrome and infective endocarditis. These defects are conventionally closed by surgery in general practice. Percutaneous closure is becoming increasingly common in recent years. While percutaneous closure was first reported in muscular defects, currently it is also used successfully for perimembranous defects. In this paper we presented a pediatric case with a single perimembranous ventricular septal defect detected on transthoracic echocardiography examination. The muscular defect was detected during the intervention and was closed percutaneously in the same session with the perimembranous defect
Keywords: Congenital heart disease, ventricular septal defect, percutaneous closure, complication
Özet
Ventriküler septal defektlerin sol kalp yetersizliği, pulmoner vasküler hastalık, Eisenmenger sendromu ve enfektif endokardit gibi muhtemel komplikasyonları sebebiyle kapatılmaları önerilmiştir. Bu defektler konvansiyonel olarak cerrahi yolla kapatılmaktadır. Son yıllarda perkütan yolla kapatma giderek yaygınlaşmaktadır. İlk olarak perkütan kapatma müsküler defektler için bildirilmişken günümüzde perimembranöz defektlerde başarılı bir şekilde kapatılabilmektedir. Bu yazıda transtorasik ekokardiyografide tek perimembranöz ventriküler septal defekt tespit edilen, perkütan kapatma işlemi sırasında müsküler septumda ikinci bir defekt saptanması ile aynı seansta perkütan yolla her iki defektin kapatıldığı bir çocuk olgu sunulmuştur.
Anahtar sözcükler: Konjenital kalp hastalığı, ventriküler septal defekt, perkütan kapatma, komplikasyon
Anahtar Kelimeler
Kaynakça
- Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57.
- Serraf A, Lacour-Gayet F, Bruniaux J, Ouaknine R, Losay J, Petit J, Binet JP, Planché C. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992; 103: 437-42.
- Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004; 43: 1257-63.
- Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer Muscular VSD Occluder: Initial results and technical considerations. Cathet Cardiovasc Interv 2000; 49: 167-72.
- Thanopoulos BD, Tsaousis GS, Karanasios E, Eleftherakis NG, Paphitis C. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart 2003; 89: 918-22.
- Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, Balzer D, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol 2006; 47: 319-25.
- Bentham JR, Gujral A, Adwani S, Archer N, Wilson N. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young 2011; 21: 271-80.
- Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM. Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 2002; 55: 355-61.
Bir çocuk hastada perimembranöz ve musküler ventriküler septal defektlerin aynı seansta perkütan yolla kapatılması
Öz
Ventriküler septal defektlerin sol kalp yetersizliği, pulmoner vasküler hastalık, Eisenmenger sendromu ve enfektif endokardit gibi muhtemel komplikasyonları sebebiyle kapatılmaları önerilmiştir. Bu defektler konvansiyonel olarak cerrahi yolla kapatılmaktadır. Son yıllarda perkütan yolla kapatma giderek yaygınlaşmaktadır. İlk olarak perkütan kapatma müsküler defektler için bildirilmişken günümüzde perimembranöz defektlerde başarılı bir şekilde kapatılabilmektedir. Bu yazıda transtorasik ekokardiyografide tek perimembranöz ventriküler septal defekt tespit edilen, perkütan kapatma işlemi sırasında müsküler septumda ikinci bir defekt saptanması ile aynı seansta perkütan yolla her iki defektin kapatıldığı bir çocuk olgu sunulmuştur
Anahtar Kelimeler
Konjenital kalp hastalığı ventriküler septal defekt perkütan kapatma komplikasyon
Kaynakça
- Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57.
- Serraf A, Lacour-Gayet F, Bruniaux J, Ouaknine R, Losay J, Petit J, Binet JP, Planché C. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992; 103: 437-42.
- Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004; 43: 1257-63.
- Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer Muscular VSD Occluder: Initial results and technical considerations. Cathet Cardiovasc Interv 2000; 49: 167-72.
- Thanopoulos BD, Tsaousis GS, Karanasios E, Eleftherakis NG, Paphitis C. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart 2003; 89: 918-22.
- Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, Balzer D, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol 2006; 47: 319-25.
- Bentham JR, Gujral A, Adwani S, Archer N, Wilson N. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young 2011; 21: 271-80.
- Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM. Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 2002; 55: 355-61.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Olgu Sunumları |
| Yazarlar | |
| Yayımlanma Tarihi | 27 Mart 2012 |
| Yayımlandığı Sayı | Yıl 2012Cilt: 34 Sayı: 1 |